UMB Bank n.a. Sells 213 Shares of Sanofi (NASDAQ:SNY)

UMB Bank n.a. decreased its holdings in Sanofi (NASDAQ:SNY) by 19.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 860 shares of the company’s stock after selling 213 shares during the period. UMB Bank n.a.’s holdings in Sanofi were worth $41,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Dimensional Fund Advisors LP boosted its holdings in shares of Sanofi by 0.4% during the second quarter. Dimensional Fund Advisors LP now owns 318,760 shares of the company’s stock worth $15,466,000 after acquiring an additional 1,238 shares during the period. Insigneo Advisory Services LLC grew its holdings in Sanofi by 3.3% in the 2nd quarter. Insigneo Advisory Services LLC now owns 7,212 shares of the company’s stock valued at $371,000 after buying an additional 228 shares in the last quarter. AQR Capital Management LLC acquired a new stake in shares of Sanofi during the second quarter worth $344,000. The Manufacturers Life Insurance Company boosted its position in shares of Sanofi by 27.3% in the second quarter. The Manufacturers Life Insurance Company now owns 31,528 shares of the company’s stock valued at $1,530,000 after acquiring an additional 6,756 shares during the period. Finally, MidWestOne Financial Group Inc. grew its stake in shares of Sanofi by 13.0% in the second quarter. MidWestOne Financial Group Inc. now owns 23,860 shares of the company’s stock valued at $1,158,000 after acquiring an additional 2,754 shares in the last quarter. 14.04% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Price Performance

Shares of NASDAQ:SNY opened at $52.48 on Friday. The firm has a 50 day moving average of $48.70 and a 200-day moving average of $52.19. Sanofi has a 12 month low of $45.22 and a 12 month high of $58.97. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $133.19 billion, a PE ratio of 26.78, a PEG ratio of 1.19 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last issued its earnings results on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The firm had revenue of $13.44 billion for the quarter, compared to the consensus estimate of $16.59 billion. During the same quarter last year, the business posted $2.55 EPS. The company’s revenue was up 12.3% compared to the same quarter last year. On average, equities research analysts predict that Sanofi will post 3.82 EPS for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.